---
title: "Hesai Group Sponsored ADR (HSAI) Gets a Buy from DBS"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286972727.md"
description: "DBS analyst Elizabelle Pang has maintained a Buy rating on Hesai Group Sponsored ADR (HSAI) with a price target of $30.00. Pang, a 3-star analyst, has an average return of 4.0% and a 58.12% success rate. The consensus on HSAI is a Strong Buy, with an average price target of $30.18."
datetime: "2026-05-19T21:35:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286972727.md)
  - [en](https://longbridge.com/en/news/286972727.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286972727.md)
---

# Hesai Group Sponsored ADR (HSAI) Gets a Buy from DBS

In a report released today, Elizabelle Pang from DBS maintained a Buy rating on Hesai Group Sponsored ADR, with a price target of $30.00.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

According to TipRanks, Pang is a 3-star analyst with an average return of 4.0% and a 58.12% success rate. Pang covers the Consumer Cyclical sector, focusing on stocks such as Hesai Group Sponsored ADR, Hesai Group Class B, and Tesla.

Currently, the analyst consensus on Hesai Group Sponsored ADR is a Strong Buy with an average price target of $30.18.

### Related Stocks

- [HSAI.US](https://longbridge.com/en/quote/HSAI.US.md)
- [02525.HK](https://longbridge.com/en/quote/02525.HK.md)
- [TSLA.US](https://longbridge.com/en/quote/TSLA.US.md)

## Related News & Research

- [Hesai sustains profitability as LiDAR shipments surge and secures Mercedes order](https://longbridge.com/en/news/286887280.md)
- [UBS Reaffirms Their Buy Rating on Hesai Group Class B (2525)](https://longbridge.com/en/news/283416708.md)
- [/C O R R E C T I O N — Hesai Group/](https://longbridge.com/en/news/285346399.md)
- [Walmart Stock: Here’s Why Analysts Are Raising Price Targets Before Q1 Earnings.](https://longbridge.com/en/news/286950969.md)
- [Q2 EPS Forecast for Avalo Therapeutics Boosted by Analyst](https://longbridge.com/en/news/286903837.md)